MY140953A - Pharmaceutical preparations for oral administration, containing ion-exchange resins loaded with pradofloxacin and intrinsically viscous gelling agents as thickening agents - Google Patents
Pharmaceutical preparations for oral administration, containing ion-exchange resins loaded with pradofloxacin and intrinsically viscous gelling agents as thickening agentsInfo
- Publication number
- MY140953A MY140953A MYPI20031984A MYPI20031984A MY140953A MY 140953 A MY140953 A MY 140953A MY PI20031984 A MYPI20031984 A MY PI20031984A MY PI20031984 A MYPI20031984 A MY PI20031984A MY 140953 A MY140953 A MY 140953A
- Authority
- MY
- Malaysia
- Prior art keywords
- oral administration
- pharmaceutical preparations
- pradofloxacin
- exchange resins
- agents
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10224086A DE10224086A1 (de) | 2002-05-31 | 2002-05-31 | Pharmazeutische Zubereitungen zur oralen Anwendung enthaltend wirkstoffbeladene Ionentauscherharze sowie strukturviskose Gelbildner als Verdicker |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY140953A true MY140953A (en) | 2010-02-12 |
Family
ID=29432468
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI20031984A MY140953A (en) | 2002-05-31 | 2003-05-29 | Pharmaceutical preparations for oral administration, containing ion-exchange resins loaded with pradofloxacin and intrinsically viscous gelling agents as thickening agents |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US8545829B2 (enExample) |
| EP (1) | EP1513500B1 (enExample) |
| JP (2) | JP5350574B2 (enExample) |
| KR (3) | KR101258373B1 (enExample) |
| CN (1) | CN1671361B (enExample) |
| AR (2) | AR039861A1 (enExample) |
| AT (1) | ATE421317T1 (enExample) |
| AU (1) | AU2003242545B2 (enExample) |
| BR (2) | BRPI0311511B1 (enExample) |
| CA (1) | CA2487648C (enExample) |
| CR (1) | CR7598A (enExample) |
| DE (2) | DE10224086A1 (enExample) |
| DK (1) | DK1513500T3 (enExample) |
| ES (1) | ES2319115T3 (enExample) |
| HR (1) | HRP20041219B1 (enExample) |
| IL (2) | IL165322A0 (enExample) |
| MX (1) | MXPA04011820A (enExample) |
| MY (1) | MY140953A (enExample) |
| NO (1) | NO333939B1 (enExample) |
| PL (1) | PL207269B1 (enExample) |
| PT (1) | PT1513500E (enExample) |
| RU (1) | RU2380091C2 (enExample) |
| SI (1) | SI1513500T1 (enExample) |
| TW (1) | TWI333422B (enExample) |
| UA (1) | UA84270C2 (enExample) |
| WO (1) | WO2003101422A2 (enExample) |
| ZA (1) | ZA200409616B (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004001558A1 (de) * | 2004-01-10 | 2005-08-18 | Bayer Healthcare Ag | Arzneimittel zur topischen Applikation bei Tieren |
| US20080095842A1 (en) * | 2004-12-06 | 2008-04-24 | Antarkar Amit K | Rapidly Disintegrating Taste Masked Compositions and a Process for Its Preparations |
| DE102005025900A1 (de) * | 2005-06-06 | 2006-12-07 | Basf Ag | Verfahren zur Entfernung von Salzen aus einem Alkoxycarbonylaminotriazin enthaltenden Reaktionsgemisch |
| US20080051332A1 (en) * | 2005-11-18 | 2008-02-28 | Nastech Pharmaceutical Company Inc. | Method of modulating hematopoietic stem cells and treating hematologic diseases using intranasal parathyroid hormone |
| CN100360131C (zh) * | 2006-01-24 | 2008-01-09 | 新昌国邦化学工业有限公司 | 一种掩味恩诺沙星的生产方法 |
| US20070248564A1 (en) * | 2006-04-25 | 2007-10-25 | Roxane Laboratories, Inc. | Formulation of sodium polystyrene sulfonate suspension for the treatment of hyperkalemia |
| CN103349659A (zh) | 2006-09-26 | 2013-10-16 | 塔罗制药北美有限公司 | 液体药物组合物以及应用 |
| DE102006049520A1 (de) | 2006-10-20 | 2008-04-24 | Bayer Healthcare Ag | Verfahren zur Herstellung von Pradofloxacin |
| US20080118570A1 (en) * | 2006-11-20 | 2008-05-22 | Zhi Liu | Polymer coated drug-ion exchange resins and methods |
| CN103550214A (zh) * | 2008-03-26 | 2014-02-05 | 塔罗制药北美有限公司 | 用于口服药剂的稳定脂质组合物 |
| PL2544532T3 (pl) | 2010-03-12 | 2017-08-31 | Monsanto Technology Llc | Agrochemiczne kompozycje żelowe |
| PH12012502132A1 (en) * | 2010-05-19 | 2013-02-04 | Astellas Pharma Inc | Pharmaceutical composition containing solifenacin |
| CN103957894A (zh) | 2011-10-19 | 2014-07-30 | R.P.谢勒技术有限公司 | 两相药物递送系统 |
| FR2998305B1 (fr) * | 2012-11-22 | 2015-02-20 | Henkel Ag & Co Kgaa | Substances actives contenant des groupes sulfonates ameliorant la puissance de lavage primaire |
| KR101697095B1 (ko) * | 2015-09-30 | 2017-01-18 | 주식회사 포스코 | 더스트 막힘을 방지할 수 있는 배가스 청정 라인의 실탱크 |
| CN111989314B (zh) | 2018-04-25 | 2024-04-30 | 拜耳动物保健有限责任公司 | 喹诺酮甲酸酯水解的方法 |
| CN114249749B (zh) * | 2022-01-08 | 2024-03-22 | 天象生物药业邢台有限责任公司 | 一种马波沙星甲酸盐的转化方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US614622A (en) * | 1898-11-22 | Machine for making billets | ||
| JPS60204713A (ja) | 1984-03-30 | 1985-10-16 | Zenyaku Kogyo Kk | 水性懸濁組成物 |
| GB8618847D0 (en) * | 1986-08-01 | 1986-09-10 | Smith Kline French Lab | Pharmaceutical formulations |
| DE3719764A1 (de) | 1987-06-13 | 1988-12-22 | Bayer Ag | Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung |
| US5338732A (en) * | 1991-06-18 | 1994-08-16 | Bristol-Myers Squibb Company | Megestrol acetate formulation |
| EP0610341B1 (en) * | 1991-10-28 | 1996-09-18 | The Procter & Gamble Company | Beverage thickener/emulsifier system |
| JP3207494B2 (ja) * | 1992-04-02 | 2001-09-10 | ロート製薬株式会社 | 水性懸濁製剤 |
| DE4319649A1 (de) * | 1993-03-18 | 1994-09-22 | Asta Medica Ag | Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe |
| NZ331468A (en) * | 1996-02-23 | 2000-02-28 | Bayer Ag | Substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo-[4,3.0]-nonan-8-yl)-6-fluoro-1, 4-dihydro-4-oxo-3-quinolin carboxylic acids and their derivatives |
| US5980882A (en) * | 1997-04-16 | 1999-11-09 | Medeva Pharmaceuticals Manufacturing | Drug-resin complexes stabilized by chelating agents |
| DE19854357A1 (de) * | 1998-11-25 | 2000-05-31 | Bayer Ag | Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure |
| SK287415B6 (sk) | 1999-07-14 | 2010-09-07 | Schering-Plough Ltd. | Vodný farmaceutický prostriedok obsahujúci chinolónovú zlúčeninu, katiónovú ionerovú živicu a farmaceuticky prijateľný excipient |
| GB9930058D0 (en) * | 1999-12-20 | 2000-02-09 | Novartis Ag | Organic compounds |
| GB0020089D0 (en) * | 2000-08-15 | 2000-10-04 | Smithkline Beecham Biolog | Vaccine Composition |
| DE10134719A1 (de) | 2001-07-17 | 2003-02-06 | Bayer Ag | Pharmazeutische Zubereitungen enthaltend wirkstoffbeladene Ionentauscherharze |
| US7001667B2 (en) * | 2002-07-17 | 2006-02-21 | Ppg Industries Ohio, Inc. | Alkyd-based free radical wood coating compositions |
-
2002
- 2002-05-31 DE DE10224086A patent/DE10224086A1/de not_active Withdrawn
-
2003
- 2003-05-19 MX MXPA04011820A patent/MXPA04011820A/es active IP Right Grant
- 2003-05-19 CA CA2487648A patent/CA2487648C/en not_active Expired - Lifetime
- 2003-05-19 UA UA20041210942A patent/UA84270C2/ru unknown
- 2003-05-19 PL PL373456A patent/PL207269B1/pl unknown
- 2003-05-19 BR BRPI0311511-9A patent/BRPI0311511B1/pt unknown
- 2003-05-19 RU RU2004139022/15A patent/RU2380091C2/ru active
- 2003-05-19 KR KR1020117031524A patent/KR101258373B1/ko not_active Expired - Lifetime
- 2003-05-19 KR KR1020127026888A patent/KR20120123607A/ko not_active Ceased
- 2003-05-19 DE DE50311123T patent/DE50311123D1/de not_active Expired - Lifetime
- 2003-05-19 DK DK03755931T patent/DK1513500T3/da active
- 2003-05-19 AT AT03755931T patent/ATE421317T1/de active
- 2003-05-19 BR BR0311511-9A patent/BR0311511A/pt active IP Right Grant
- 2003-05-19 ES ES03755931T patent/ES2319115T3/es not_active Expired - Lifetime
- 2003-05-19 AU AU2003242545A patent/AU2003242545B2/en not_active Expired
- 2003-05-19 US US10/516,344 patent/US8545829B2/en not_active Expired - Fee Related
- 2003-05-19 CN CN038182106A patent/CN1671361B/zh not_active Expired - Lifetime
- 2003-05-19 IL IL16532203A patent/IL165322A0/xx unknown
- 2003-05-19 KR KR10-2004-7019371A patent/KR20050010015A/ko not_active Ceased
- 2003-05-19 SI SI200331534T patent/SI1513500T1/sl unknown
- 2003-05-19 JP JP2004508780A patent/JP5350574B2/ja not_active Expired - Lifetime
- 2003-05-19 HR HRP20041219AA patent/HRP20041219B1/hr not_active IP Right Cessation
- 2003-05-19 EP EP03755931A patent/EP1513500B1/de not_active Expired - Lifetime
- 2003-05-19 PT PT03755931T patent/PT1513500E/pt unknown
- 2003-05-19 WO PCT/EP2003/005228 patent/WO2003101422A2/de not_active Ceased
- 2003-05-28 AR ARP030101867A patent/AR039861A1/es not_active Application Discontinuation
- 2003-05-29 MY MYPI20031984A patent/MY140953A/en unknown
- 2003-05-30 TW TW092114643A patent/TWI333422B/zh not_active IP Right Cessation
-
2004
- 2004-11-22 IL IL165322A patent/IL165322A/en active IP Right Grant
- 2004-11-24 CR CR7598A patent/CR7598A/es not_active Application Discontinuation
- 2004-11-29 ZA ZA200409616A patent/ZA200409616B/xx unknown
- 2004-12-29 NO NO20045700A patent/NO333939B1/no not_active IP Right Cessation
-
2010
- 2010-10-20 JP JP2010235021A patent/JP2011012087A/ja not_active Withdrawn
-
2016
- 2016-08-23 AR ARP160102580A patent/AR105798A2/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY140953A (en) | Pharmaceutical preparations for oral administration, containing ion-exchange resins loaded with pradofloxacin and intrinsically viscous gelling agents as thickening agents | |
| BR0008590A (pt) | Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto | |
| DK0739197T3 (da) | Konserverede oftalmiske lægemiddelpræparater, som indeholder polymere kvaternære ammoniumforbindelser | |
| BR0015256A (pt) | Composições farmacêuticas contendo uma droga de antibiótico de fluoroquinolona e uma goma de xantano | |
| TR200100054T2 (tr) | Paroksetin metansülfonat | |
| DE50005529D1 (de) | Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac | |
| PT1411921E (pt) | Composições farmacêuticas contendo terbinafina e suas utilizações | |
| DE60019334D1 (de) | Antivirale arznei | |
| PT1121127E (pt) | Composicoes farmaceuticas orais contendo buprenorfina | |
| SE9802208D0 (sv) | Novel compounds | |
| SE0300908D0 (sv) | Azaindole derivatives, preparations thereof, uses thereof and compositions containing them | |
| IL173369A (en) | Combined pharmaceutical preparation containing g - csf and p1gf effective in stimulating mobilization of peripheral blood progenitor cells | |
| GR20020100478A (el) | Ανυδρη κρυσταλλικη μορφη της βαλακyκλοβιρης υδροχλωρικης | |
| SE9802209D0 (sv) | Novel compounds | |
| ITRM20010325A0 (it) | Composizioni farmaceutiche a base di zeoliti contenenti zinco ed eritromicina da impiegare nella terapia anti-acne. | |
| MXPA05012297A (es) | Indazol que tiene actividad analgesica. | |
| HUP0200729A3 (en) | Hydroxamic acid derivatives, their use and preparation and pharmaceutical compositions containing them | |
| PT1144420E (pt) | Fosfatidilinositois sulfatados a sua preparacao e a sua utilizacao | |
| IL166596A0 (en) | Salt of morphine-6-glucoronide | |
| SE0203817D0 (sv) | New composition | |
| PL1663101T3 (pl) | Postać stosowana do doustnego podawania substancji czynnych, witamin i/lub substancji odżywczych, zestaw i zastosowanie | |
| AU6553900A (en) | Water-soluble cephalomannine esters with poly-amino-acid or the salts thereof, pharmaceutical compositions containing them and their use in medicine | |
| MXPA05012117A (es) | Derivados de diarilmetiliden piperidina, preparaciones de los mismos y usos de los mismos. | |
| SE0102309D0 (sv) | Farmaceutisk engång-om-dagen-komposition innehållande brivudin | |
| DE50211461D1 (de) | Pharmazeutische zusammensetzung enthaltend bulbophyllum |